#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal muscular atrophy Haemophilia B without inhibitors Corneal neovascularisation Non-small cell lung cancer recurrent Immune-mediated myasthenia gravis Immunodeficiency common variable Neurotrophic keratopathy Endometrial adenocarcinoma Myelin oligodendrocyte glycoprotein antibody-associated disease Alveolar rhabdomyosarcoma Cardiac arrest Liposarcoma metastatic ROHHAD syndrome Cutaneous T-cell lymphoma Myelofibrosis More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Life with Disease Propionic acidaemia – Treatment Primary biliary cholangitis – Life with Disease Leiomyosarcoma – Treatment Haemophilia A with anti factor VIII – Life with Disease Lymphangioma – Trials in Disease Basal cell naevus syndrome – Basic Information Chronic granulomatous disease – Basic Information Glomerulonephritis membranoproliferative – Trials in Disease Synovial sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pevonedistat Cx-037231 Teprotumumab Ublituximab Efinopegdutide Satralizumab Relebactam Sodium Chloride Solution 0.9% Ecoo25B Tianeptine Bevacizumab Zirconium Zr-89 Ep0031 GSK5460025A L-LEUCINE Landiolol Hydrochloride Specific Nucleic Acid Sna-Xfsb Cabergoline Ltp001 Arsenic Trioxide Ribociclib More therapies…

    Learn about Your Condition

    Bronchiectasis Hip arthroplasty Pertussis Mucopolysaccharidosis II Choroid melanoma Cortical dysplasia Diffuse large B-cell lymphoma Bronchostenosis Tachypnoea Viral infection Immune-mediated enterocolitis Spinal muscular atrophy Acute promyelocytic leukaemia Dysmenorrhoea Blood disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

B-cell lymphoma

  • Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • B-cell lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • Autologous T-Cells Encoding A Chimeric Antigen Receptor Targeting Human B Cell Maturation Antigen
    • Rapcabtagene Autoleucel
    • Tisagenlecleucel
    Austria Belgium Denmark Finland France Germany +6

  • Study on Glofitamab and Drug Combination for Children and Young Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Ifosfamide
    • Carboplatin
    • Etoposide
    Czechia Denmark France Germany Hungary Italy +2

  • Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin’s Lymphoma and Chronic Graft Versus Host Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Graft versus host disease
    Investigated Drugs:
    • Ibrutinib
    • Nivolumab
    Belgium France Germany Greece Italy Poland +2

  • Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma refractory
    • B-cell lymphoma
    Investigated Drugs:
    • Alemtuzumab
    • Ucart20X22
    • Aldesleukin
    France Italy Spain

  • Study of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • B-cell lymphoma
    Investigated Drugs:
    • Pembrolizumab
    France Germany Italy The Netherlands Portugal Sweden

  • Study on the Safety and Effectiveness of AZD5492 Alone or with Other Treatments for Adults with Relapsed or Refractory B-Cell Blood Cancers

    Recruiting

    1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Azd5492
    Denmark France Germany Italy Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!